The 7th International Conference On Clinical and Engineering Frontiers in Pediatric and Congenital Heart Disease

第七届小儿和先天性心脏病临床和工程前沿国际会议

• 批准号: 9763076
• 负责人: Mark A Fogel
• 金额: $ 1.75万
• 依托单位: CHILDREN'S HOSP OF PHILADELPHIA
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-05-09 至 2020-05-08
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9763076
• 关键词: Adult; Award; Biomedical Engineering; Birth; Cause of Death; Childhood; Clinical; Clinical Engineering; Clinical Medicine; Collaborations; Communities; Congenital Abnormality; Country; Defect; Diagnostic; Discipline; Disease; Engineering; Faculty; Fostering; Funding; Goals; Individual; International; Mechanics; Medical; Medical Care Costs; Medicine; Minority Participation; Oral; Participant; Patients; Physicians; Population; Quality of life; Research; Research Personnel; STEM field; Scientist; Series; Societies; Source; Technology; Travel; Underrepresented Groups; Underrepresented Minority; Universities; Ursidae Family; Woman; age related; congenital heart disorder; doctoral student; frontier; graduate student; hemodynamics; improved; infant death; meetings; member; next generation; posters; programs; research and development; role model; symposium; tool; treatment planning

Project Summary and Abstract Congenital heart disease (CHD) is the leading cause of death for infants born with birth defects and represents 1% of births in the US. Successful treatment of CHD offers opportunities to improve quality of life for these individuals with consequent benefit to society. Over 1 million adults in the US are living with CHD. While there has been much progress with applying engineering fundamentals to understand and CHD over the past decades, there remains more to accomplish. To help focus engineers and physicians, the 6th International Conference on Clinical and Engineering Frontiers in Pediatric and Congenital Heart Disease, the meeting this project proposes, will bring together leading professionals in both engineering and medical disciplines to foster collaboration between the 2 communities in the study of treatment of CHD. Concurrently, the conference will serve as a platform to encourage the next generation of engineers and scientists to continue pursuing treatments for CHD. By bringing together these 2 groups, there is an opportunity to advance current treatment, identify under- researched defects and bring engineering to bear as an aid to physicians in understanding hemodynamic and mechanical aspects of the disease, improving and developing diagnostic tools and technology, and improving treatment planning. Therefore, a conference focused on CHD can achieve improved treatment and understanding of this age-related disease that afflicts a significant segment of the US population and the consequent reduction of medical costs associated with CHD accompanied by an improved patient quality of life. The conference will offer support to members of underrepresented groups involved in biomedical engineering research in pediatric and congenital heart disease, thus upholding the national goal of engaging underrepresented groups into the STEM disciplines. This conference also provides successful role models for women, 2 who are on the international organizing and steering committee, who have established vibrant research programs and labs in this field. This is the 6th iteration of this conference and we seek to maintain the continuity of the International Conference on Clinical and Engineering Frontiers in Pediatric and Congenital Heart Disease series that effectively brings together leading researchers in engineering and medicine who are engaged in cutting edge research in CHD. This is an excellent forum to exchange ideas and build of collaborations between leading researchers from around the world. Moreover, the conference promotes new researchers becoming engaged in the field through the Young Investigator podium speaker program and its young investigator poster competition. Our conference objective is to request support for the 6th in this series of international conferences on the engineering research in pediatric and congenital heart disease which has historically attracted both USA and international participants, affording an international forum for exchange of ideas and research.

项目摘要和摘要 先天性心脏病（CHD）是出生缺陷的婴儿的主要死亡原因，代表 在美国的1％的出生。成功治疗CHD为这些冠心病提供了改善生活质量的机会 因此对社会有利的个人。在美国，有超过100万成年人生活在冠心病人中。那里 在过去的几十年中，应用工程基础来理解和CHD取得了很多进展， 还有更多要完成的。为了帮助重点工程师和医生，第六届国际会议 小儿和先天性心脏病的临床和工程前沿，该项目的会议提出， 将汇集工程和医学学科的领先专业人员，以促进合作 在两个社区研究冠心病治疗的研究中。同时，会议将作为 鼓励下一代工程师和科学家继续为CHD寻求治疗的平台。 通过将这两个小组汇总在一起，有机会进步当前的治疗，确定不足 研究缺陷，并使工程学成为对医生了解血液动力学和的帮助 疾病的机械方面，改善和开发诊断工具和技术，并改善 治疗计划。因此，以CHD为重点的会议可以提高治疗方法，并且 了解这种与年龄相关的疾病，遭受了美国人口的很大一部分 随之而来的与CHD相关的医疗费用伴随着改善的患者生活质量。 会议将为参与生物医学的代表性不足的团体的成员提供支持 小儿和先天性心脏病的工程研究，从而坚持参与的国家目标 代表人数不足的群体进入了茎学科。该会议还为成功的榜样提供了 妇女，2岁的国际组织和指导委员会，她建立了充满活力的妇女 该领域的研究计划和实验室。 这是本次会议的第六次迭代，我们试图维持国际的连续性 小儿和先天性心脏病系列的临床和工程前沿会议 有效地汇集了从事尖端的工程和医学研究人员 CHD的研究。这是一个很好的论坛 来自世界各地的研究人员。此外，会议促进了新的研究人员参与 通过年轻的调查员讲台演讲者计划及其年轻调查员海报竞赛的领域。 我们的会议目的是在这一系列国际会议上要求支持第六 历史上吸引了两者的小儿和先天性心脏病的工程研究 和国际参与者，为交流思想和研究提供国际论坛。